Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.36 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26634462 | 0.95 | PDK2 (0.45) | PDK2BCHEACHENOX1HPGD | |
| SCHEMBL26634459 | 0.91 | PDK2 (0.42) | PDK2BCHEACHENOX1HPGD | |
| SCHEMBL23372411 | 0.91 | PDK2 (0.49) | PDK2BCHEACHENOX1HPGD | |
| SCHEMBL23372416 | 0.88 | PDK2 (0.51) | PDK2BCHEACHENOX1HPGD | |
| SCHEMBL19383292 | 0.88 | PDK2 (0.54) | PDK2L3MBTL1AKR1A1AKR1B1PGR | |
| SCHEMBL23372313 | 0.88 | BCHE (0.47) | PDK2BCHEACHENOX1HPGD | |
| SCHEMBL22891491 | 0.88 | PDK2 (0.47) | PDK2BCHEACHENOX1HPGD | |
| SCHEMBL17816710 | 0.86 | BCHE (0.46) | PDK2BCHEACHENOX1HPGD | |
| SCHEMBL23382843 | 0.86 | PDK2 (0.40) | PDK2BCHEACHENOX1L3MBTL1 | |
| SCHEMBL22797227 | 0.85 | PDK2 (0.52) | PDK2AKR1A1AKR1B1PGRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11563182-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-01-24 | — | — | US | disclosed |
| US-20220376185-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220376185-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | TCF7, MCM7, LUC7L2 | PDK2 2530/4885BCHE 3018/4885ACHE 1693/4885 |
| US-11563182-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | TCF7, MCM7, LUC7L2 | PDK2 2530/4885BCHE 3018/4885ACHE 1693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.